L&C BIO Co.,LTD (KOSDAQ:290650)

South Korea flag South Korea · Delayed Price · Currency is KRW
53,500
+1,000 (1.90%)
Oct 30, 2025, 3:30 PM KST
1.90%
Market Cap1.32T
Revenue (ttm)75.98B
Net Income (ttm)124.29B
Shares Out24.62M
EPS (ttm)4,923.41
PE Ratio10.73
Forward PEn/a
Dividend50.00 (0.10%)
Ex-Dividend DateDec 27, 2024
Volume586,532
Average Volume727,943
Open52,700
Previous Close52,500
Day's Range51,800 - 55,500
52-Week Range15,000 - 67,900
Beta0.97
RSI53.80
Earnings DateNov 14, 2025

About L&C BIO Co.,LTD

L&C Bio Co., Ltd operates as a research and development company in tissue regeneration medicine. It offers human tissue, medical device, and cosmetics products. The company was founded in 2011 and is headquartered in Seongnam-si, South Korea. [Read more]

Industry Medical - Specialties
Sector Healthcare
Founded 2011
Employees 142
Stock Exchange KOSDAQ
Ticker Symbol 290650
Full Company Profile

Financial Performance

In 2024, L&C BIO Co.,LTD's revenue was 72.09 billion, an increase of 9.35% compared to the previous year's 65.93 billion. Earnings were 141.06 billion, an increase of 191.69%.

Financial Statements

News

There is no news available yet.